Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

660 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects.
Huang K, Que L, Ding Y, Chu N, Qian Z, Shi Y, Qin W, Li Z, Chen Y, Gu X, Wang J, Zhang L, Zhang J, Zhu X, Yang Y, Tang Y, He Q. Huang K, et al. Among authors: que l. Front Pharmacol. 2021 Jun 17;12:694375. doi: 10.3389/fphar.2021.694375. eCollection 2021. Front Pharmacol. 2021. PMID: 34220519 Free PMC article.
Safety, Tolerability, and Pharmacokinetic Study of 101BHG-D01 Nasal Spray, a Novel Long-Acting and Selective Cholinergic M Receptor Antagonist, in Healthy Chinese Volunteers: A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation, First-In-Human Study.
Chu NN, Huang K, Que LL, Ding Y, Gu XH, Zhang L, Wang JK, Chen XP, Sun ZG, He Q. Chu NN, et al. Among authors: que ll. Eur J Drug Metab Pharmacokinet. 2022 Jul;47(4):509-521. doi: 10.1007/s13318-022-00769-6. Epub 2022 Apr 16. Eur J Drug Metab Pharmacokinet. 2022. PMID: 35429285 Clinical Trial.
660 results